The clearance of Keytruda QLEX follows similar approvals for Bristol Myers and Roche. Elsewhere, MBX’s parathyroidism drug ...

The collapse in value of many biotechs over the past few years has created an opportunity for specialists like Xoma to “do ...

After an earlier rejection that drew criticism from some observers, the FDA quickly accepted Stealth BioTherapeutics’ new ...

The company, which is developing a competitor to Cobenfy, aims to become one of rare biotechs to price a large IPO of late.

The deal ends a short run as a publicly traded company for Metsera, which is being sold for more than double its IPO price ...

Being proactive — especially when it comes to testing, process development and preparing for commercialization — can greatly decrease the risk that your CGT will receive a CRL.

An advisory committee to the Centers for Disease Control and Prevention urged people consult their physicians on the benefits and risks of receiving a COVID-19 vaccine, voting Friday to recommend ...

Members of ACIP voted to table a planned vote on withholding some infants’ first hepatitis B vaccine dose, adding more ...

Pfizer and Arvinas plan to out-license their partnered drug vepdegestrant. Elsewhere, Novo shared more data for oral Wegovy ...

Thanks to a partnership with Ionis Pharmaceuticals, Biogen has a long history with antisense oligonucleotides, which can modify the production of proteins in the body. The two companies developed the ...

The committee reconvened Friday to re-do a vote on coverage of the combined MMRV shot through the Vaccines for Children ...